Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07186192 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

StatusRecruiting
PhasePhase 3
Started2026-01-14
View on ClinicalTrials.gov ↗

Amendment history

2026-08-26
Study Status, Study Design v5
Enrollment increased: 190 → 380 participants
2026-01-27
Study Status v4
Start dateestimated 2025-12-15→confirmed 2026-01-14
2025-10-27
Study Status v3
Start date2025-10-15→2025-12-15
2025-10-14
Study Status, Study Design, Arms and Interventions, Eligibility v2
PhaseNot specified→Phase 3
InterventionsIntervention Arm (Digital health intervention) (Other), Standard of Care Arm (Enhanced usual care) (Other)→Best Practice (Other), Educational Intervention (Other), Health Telemonitoring (Procedure), Questionnaire Administration (Other)
2025-09-29
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2029-04-15→2029-03-29
Completion date2029-10-14→2029-03-29
Study sites0→1
2025-09-12
Original filing
The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
Trial Details
NCT Number NCT07186192
Lead Sponsor City of Hope Medical Center
Collaborators: United States Department of Defense
Conditions Hematologic Malignancies
Enrollment 380 participants
Start Date 2026-01-14
Primary Completion 2029-03-29 (estimated)
Study Completion 2029-03-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-28